Search

everythinglearnresearchcommunity

for

Search:↓

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Co-trimoxazole may help treat autoimmune diseases.

The new formulation improves dutasteride's absorption when taken orally.

PUVASOL might effectively treat complete scalp baldness.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

The research developed new fortilin protein constructs for potential heart disease treatments.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Immunoadsorption successfully treated a man's resistant polymyositis.

Selencin effectively reduces hair loss and improves hair health in diffuse alopecia.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Ethanol and methanol extracts of Spirulina platensis do not kill WiDr colon cancer cells.

Transcutol P best increases Finasteride absorption for hair loss treatment.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Apremilast shows promise for several skin conditions but needs more research.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Better diagnosis and control of thallium poisoning are needed to prevent severe outcomes.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.